Philadelphia, PA— The market access, pricing, and reimbursement landscape is rapidly evolving as stakeholders shift to a value-based healthcare system. The transition to a value-based healthcare system, coupled with increasing drug pricing scrutiny and mounting uncertainty related to potential repeal or replacement of the Affordable Care Act, creates tremendous challenges for biopharma manufacturers to overcome.
Samir Mistry, Vice President of Rebates and Pricing Strategies for Abarca Health, will advise pharmacy leaders on the shift to a value-based as a panelist in for Reimbursement & Access 2017, the most important conference related market access, pricing, and reimbursement in the United States. Other participants include Rashmi Agarwal, Assistant Director of the U.S. Government Accountability Office, Ira Klein, Senior Director at Johnson & Johnson, Gergana Zlateva, Vice President of Payer Insights and Access at Pfizer, among other leaders.
Join Samir in Philadelphia this August 16-17 at fifth annual Reimbursement and Access 2017. Hundreds of leaders in access, reimbursement, managed markets and commercial operations will benefit from this highly-acclaimed event which arms attendees with best practices and practical strategies during a time of unprecedented uncertainty on complex issues.